 | Up a level |
Seibold, Frank Werner (2013). PPI: Sicher oder doch nicht? Zu wenig oder doch zu häufig verschrieben? Ars medici - Schweizer Zeitschrift für Hausarztmedizin, 4, p. 205. Rosenfluh
Seibold, F (2008). Editorial zur Antikörpertherapie bei IBD. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(1), p. 3. Neuhausen (CH): Rosenfluh
Vavricka, Stephan R; Gubler, Martin; Gantenbein, Claudine; Spoerri, Muriel; Froehlich, Florian; Seibold, Frank; Protic, Marijana; Michetti, Pierre; Straumann, Alex; Fournier, Nicolas; Juillerat, Pascal; Biedermann, Luc; Zeitz, Jonas; Misselwitz, Benjamin; Scharl, Michael; Heinrich, Henriette; Manser, Christine N; Safroneeva, Ekaterina; Raja Ali, Raja Affendi; Rogler, Gerhard; ... (2017). Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflammatory bowel diseases, 23(7), pp. 1174-1181. Lippincott Williams & Wilkins 10.1097/MIB.0000000000001109
Safroneeva, Ekaterina; Vavricka, S; Fournier, N; Seibold, Frank Werner; Mottet, C; Nydegger, A; Ezri, J; Straumann, A; Rogler, G; Schoepfer, A M; Juillerat, Pascal; Swiss IBD Cohort, Study Group (2015). Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients. Alimentary pharmacology & therapeutics, 42(5), pp. 540-548. Wiley-Blackwell 10.1111/apt.13307
Vavricka, Stephan R; Rogler, Gerhard; Gantenbein, Claudine; Spoerri, Muriel; Prinz Vavricka, Mareike; Navarini, Alexander A; French, Lars E; Safroneeva, Ekaterina; Fournier, Nicolas; Straumann, Alex; Froehlich, Florian; Fried, Michael; Michetti, Pierre; Seibold, Frank Werner; Lakatos, Peter L; Peyrin-Biroulet, Laurent; Schoepfer, Alain M (2015). Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflammatory bowel diseases, 21(8), pp. 1794-1800. Lippincott Williams & Wilkins 10.1097/MIB.0000000000000429
Juillerat, Pascal; Peter, M; Macpherson, James; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (February 2015). Measurement of functional blocade of TNF-alpha by anti-TNF agents is a stronger predictor than trough levels and anti-drug antibodies: 2-year prospective clinical data (Unpublished). In: European Crohn’s and colitis organization congress (ECCO). Barcelona. Februar 2015.
Juillerat, Pascal; Andrew, Peter; Macpherson, James; Slack, Emma; Seibold, Frank Werner; Cahenzli, Julia; McCoy, Kathleen; Macpherson, Andrew (2015). Measurement of functional blocade of TNF-alpha by anti-TNF agents is a stronger predictor than trough levels and anti-drug antibodies: 2-year prospective clinical data. Gastroenterology, 148(4), pp. 850-1. Elsevier
Schaffer, Thomas; Schoepfer, Alain M; Seibold, Frank Werner; Juillerat, Pascal; Swiss Inflammatory Bowel Diseases Cohort Study Group, The (2014). Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity. Journal of Crohn's & Colitis, 8(9), pp. 1125-1132. Oxford University Press 10.1016/j.crohns.2014.02.014
Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier
Cleynen, I.; Vazeille, E.; Artieda, M.; Verspaget, H. W.; Szczypiorska, M.; Bringer, M.-A.; Lakatos, P. L.; Seibold, Frank Werner; Parnell, K.; Weersma, R. K.; Mahachie John, J. M.; Morgan-Walsh, R.; Staelens, D.; Arijs, I.; De Hertogh, G.; Müller, Stefan Jürg; Tordai, A.; Hommes, D. W.; Ahmad, T.; Wijmenga, C.; ... (2014). Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease. Gut, 63(8), pp. 1265-1274. BMJ Publishing Group 10.1136/gutjnl-2012-303205
Protic, Marijana; Seibold, Frank Werner; Schöpfer, Alain; Radojicic, Zoran; Juillerat, Pascal; Bojic, Daniela; Mwinyi, Jessica; Mottet, Christian; Jojic, Njegica; Beglinger, Christoph; Vavricka, Stephan; Rogler, Gerhard; Frei, Pascal (2014). The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients. Journal of Crohn's & Colitis, 8(11), pp. 1427-1437. Elsevier 10.1016/j.crohns.2014.05.004
Sauter, Bernhard; Beglinger, Christoph; Girardin, Marc; Macpherson, Andrew; Michetti, Pierre; Schoepfer, Alain; Seibold, Frank Werner; Vavricka, Stephan R; Rogler, Gerhard (2014). Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendations. Digestion, 89(4), pp. 299-309. Karger 10.1159/000360283
Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer Ärzteverlag
Siebert, Uwe; Wurm, Johannes; Gothe, Raffaella Matteucci; Arvandi, Marjan; Vavricka, Stephan R.; von Känel, Roland; Begré, Stefan; Sulz, Michael C.; Meyenberger, Christa; Sagmeister, Markus; Müller, Christoph; Seibold, Frank Werner; the Swiss IBD Cohort Study Group, (Müller C) (2013). Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study. Inflammatory bowel diseases, 19(4), pp. 847-855. Lippincott Williams & Wilkins 10.1097/MIB.0b013e31827f278e
Vavricka, Stephan R.; Manser, Christine N.; Hediger, Sebastian; Vögelin, Marius; Scharl, Michael; Biedermann, Luc; Rogler, Sebastian; Seibold, Frank Werner; Sanderink, René; Attin, Thomas; Schoepfer, Alain; Fried, Michael; Rogler, Gerhard; Frei, Pascal (2013). Periodontitis and Gingivitis in Inflammatory Bowel Disease. Inflammatory bowel diseases, 19(13), pp. 2768-2777. Lippincott Williams & Wilkins 10.1097/01.MIB.0000438356.84263.3b
Biedermann, Luc; Rogler, Gerhard; Vavricka, Stephan R; Seibold, Frank; Seirafi, Mariam (2012). Pregnancy and breastfeeding in inflammatory bowel disease. Digestion, 86 Suppl 1, pp. 45-54. Basel: Karger 10.1159/000341941
Lottaz, Daniel; Maurer, Christoph A; Noël, Agnès; Blacher, Silvia; Huguenin, Maya; Nievergelt, Alexandra; Niggli, Verena; Kern, Alexander; Müller, Stefan; Seibold, Frank; Friess, Helmut; Becker-Pauly, Christoph; Stöcker, Walter; Sterchi, Erwin E (2011). Enhanced activity of meprin-?, a pro-migratory and pro-angiogenic protease, in colorectal cancer. PLoS ONE, 6(11), e26450. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0026450
Vavricka, Stephan R; Schoepfer, Alain M; Bansky, Georg; Binek, Janek; Felley, Christian; Geyer, Martin; Manz, Michael; Rogler, Gerhard; de Saussure, Philippe; Sauter, Bernhard; Scharl, Michael; Seibold, Frank; Straumann, Alex; Michetti, Pierre; Swiss, IBDnet (2011). Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflammatory bowel diseases, 17(7), pp. 1530-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21521
Rossin, Elizabeth J.; Lage, Kasper; Raychaudhuri, Soumya; Xavier, Ramnik J.; Tatar, Diana; Seibold, Frank Werner; Benita, Yair; Cotsapas, Chris; Daly, Mark J.; International Inflammatory Bowel Disease Genetics, Constortium (2011). Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS genetics, 7(1), e1001273. San Francisco, Calif.: Public Library of Science 10.1371/journal.pgen.1001273
Schoepfer, Alain M.; Vavricka, Stephan R.; Binek, Janek; Felley, Christian; Geyer, Martin; Manz, Michael; Rogler, Gerhard; de Saussure, Philippe; Sauter, Bernhard; Seibold, Frank; Straumann, Alex; Michetti, Pierre (2010). Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohnʼs disease population. Inflammatory bowel diseases, 16(6), pp. 933-938. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21127
Juillerat, Pascal; Pittet, Valérie; Vader, John-Paul; Burnand, Bernard; Gonvers, Jean-Jacques; de Saussure, Philippe; Mottet, Christian; Seibold, Frank; Rogler, Gerhard; Sagmeister, Markus; Felley, Christian; Michetti, Pierre; Froehlich, Florian; Swiss IBD Cohort Study Group, The (2010). Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness. European journal of gastroenterology & hepatology, 22(11), pp. 1352-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MEG.0b013e32833eaa8a
Pittet, V; Juillerat, P; Michetti, P; Vader, J-P; Burnand, B; Rogler, G; Beglinger, C; Seibold, F; Mottet, C; Felley, C; Gonvers, J-J; Froehlich, F; Swiss IBD Cohort Study Group, The (2010). Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort. Alimentary pharmacology & therapeutics, 32(8), pp. 1007-16. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2010.04434.x
Seibold, Frank; Schoepfer, Alain M (2009). Can fecal calprotectin or lactoferrin identify postoperative recurrence in Crohn's disease? Inflammatory bowel diseases, 16(10), pp. 1814-1815. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21173
Schoepfer, Alain M; Schaffer, Thomas; Mueller, Stefan; Flogerzi, Beatrice; Vassella, Erik; Seibold-Schmid, Beatrice; Seibold, Frank (2009). Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort. Inflammatory bowel diseases, 15(9), pp. 1358-67. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20892
Schoepfer, AM; Beglinger, C; Straumann, A; Trummler, M; Renzulli, P; Seibold, F (2009). Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflammatory bowel diseases, 15(12), pp. 1851-1858. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20986
Schoepfer, A; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2008). Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflammatory bowel diseases, 14(1), pp. 32-39. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20275
Seibold, F (2008). What is the optimal maintenance treatment for Crohn's disease. Inflammatory bowel diseases, 14(Suppl. 2), S255-S256. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20672
Schaffer, T; Mueller, S; Flogerzi, B; Seibold-Schmid, B; Schoepfer, A; Seibold, F (2007). Anti-Saccharomyces cerevisiae antibodies in Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflammatory bowel diseases, 13(11), pp. 1339-1346. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20228
Seibold, F; Boldt, AB; Seibold-Schmid, B; Schoepfer, AM; Flogerzi, B; Mueller, S; Kun, JF (2007). Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: A family study. Inflammatory bowel diseases, 13(9), pp. 1077-1082. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20156
Schenk, Mirjam; Bouchon, Axel; Seibold, Frank; Mueller, Christoph (2007). TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. Journal of clinical investigation, 117(10), pp. 3097-3106. Ann Arbor, Mich.: American Society for Clinical Investigation 10.1172/JCI30602
Schüpbach, W; Vadday, K; Schaller, A; Brekenfeld, C; Kappeler, L; Benoist, JF; Xuan-Huong, C; Burgunder, J; Seibold, F; Gallati, S; Mattle, H (2007). Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features. Journal of neurology, 254(2), pp. 146-53. Heidelberg: Steinkopff-Verlag; www.steinkopff.springer.de 10.1007/s00415-006-0255-3
Luckschander, Nicole; Allenspach, Karin; Hall, Jean; Seibold, Frank; Gröne, Andrea; Doherr, Marcus G; Gaschen, Frédéric (2006). Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease. Journal of veterinary internal medicine, 20(2), pp. 221-7. Oxford: Wiley-Blackwell 10.1892/0891-6640(2006)20[221:PACAAR]2.0.CO;2
Müller, Stefan; Schaffer, Thomas; Flogerzi, Beatrice; Fleetwood, Andrew; Weimann, Rosemarie; Schoepfer, Alain M; Seibold, Frank (2006). Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD. Inflammatory bowel diseases, 12(7), pp. 588-97. Hagerstown, Md.: Lippincott Williams & Wilkins
Broedl, UC; Schachinger, V; Lingenhel, A; Lehrke, M; Stark, R; Seibold, F; Goke, B; Kronenberg, F; Parhofer, KG; Konrad-Zerna, A (2006). Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflammatory bowel diseases, 13(4), pp. 391-397. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20078
Konrad, Astrid; Mähler, Michael; Arni, Stephan; Flogerzi, Beatrice; Klingelhöfer, Sonja; Seibold, Frank Werner (2005). Ameliorative effect of IDS 30, a stinging nettle leaf extract, on chronic colitis. International journal of colorectal disease, 20(1), pp. 9-17. Springer 10.1007/s00384-004-0619-z
